loading
Citius Oncology Inc stock is traded at $1.72, with a volume of 57,627. It is down -0.58% in the last 24 hours and down -15.27% over the past month. Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.
See More
Previous Close:
$1.73
Open:
$1.76
24h Volume:
57,627
Relative Volume:
0.24
Market Cap:
$134.80M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
-15.27%
6M Performance:
+98.11%
1Y Performance:
+45.15%
1-Day Range:
Value
$1.715
$1.78
1-Week Range:
Value
$1.68
$1.93
52-Week Range:
Value
$0.5506
$6.19

Citius Oncology Inc Stock (CTOR) Company Profile

Name
Name
Citius Oncology Inc
Name
Phone
(908) 967-6677
Name
Address
11 COMMERCE DRIVE, CRANFORD
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
CTOR's Discussions on Twitter

Compare CTOR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
CTOR
Citius Oncology Inc
1.72 144.48M 0 0 0 0.00
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
143.89 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.38 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.245 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.11 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
442.37 19.53B 3.08B 1.24B 1.07B 25.61

Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-23-25 Upgrade Maxim Group Hold → Buy
Nov-27-24 Initiated Maxim Group Buy

Citius Oncology Inc Stock (CTOR) Latest News

pulisher
06:47 AM

Building trade automation scripts for Citius Oncology Inc.Weekly Trading Summary & Stock Portfolio Risk Management - newser.com

06:47 AM
pulisher
06:21 AM

Regression analysis insights on Citius Oncology Inc. performanceMarket Volume Report & Detailed Earnings Play Strategies - newser.com

06:21 AM
pulisher
06:04 AM

Predicting Citius Oncology Inc. trend using moving averagesMarket Sentiment Summary & Daily Profit Focused Stock Screening - newser.com

06:04 AM
pulisher
05:58 AM

Why retail investors favor Citius Oncology Inc. stockQuarterly Earnings Report & Technical Pattern Recognition Alerts - newser.com

05:58 AM
pulisher
05:58 AM

Real time social sentiment graph for Citius Oncology Inc.2025 Market Sentiment & Community Consensus Trade Alerts - newser.com

05:58 AM
pulisher
05:25 AM

What the charts say about Citius Oncology Inc. todayTrade Volume Report & Weekly Market Pulse Updates - newser.com

05:25 AM
pulisher
Oct 30, 2025

What data driven models say about Citius Oncology Inc.’s futureAnalyst Downgrade & Weekly Watchlist for Hot Stocks - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

News impact scoring models applied to Citius Oncology Inc.2025 Short Interest & Reliable Price Action Trade Plans - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

How Citius Oncology Inc. stock benefits from strong dollarJuly 2025 Momentum & Entry and Exit Point Strategies - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Published on: 2025-10-29 00:05:52 - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Published on: 2025-10-28 05:08:21 - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Citius Oncology Inc. stock a buy on dipsM&A Rumor & Weekly High Momentum Picks - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

What high frequency data says about Citius Oncology Inc.Trend Reversal & Entry and Exit Point Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is Citius Oncology Inc. stock attractive for long term wealth buildingAnalyst Upgrade & Community Verified Watchlist Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Citius Oncology Stockholders Approve Share Increase - TipRanks

Oct 27, 2025

Citius Oncology Inc Stock (CTOR) Financials Data

There is no financial data for Citius Oncology Inc (CTOR). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$45.44
price up icon 2.97%
drug_manufacturers_specialty_generic RDY
$13.31
price down icon 0.99%
$22.45
price down icon 0.55%
$10.36
price down icon 0.05%
$141.21
price up icon 2.30%
$442.61
price down icon 2.40%
Cap:     |  Volume (24h):